Anti-doping (IAAF)


IAAF commitment to healthy and drug free athletics

The IAAF is proudly committed to keeping its athletes healthy and to its zero-tolerance policy with respect to doping.

As early as 1928 at the Amsterdam Congress, the first Anti-Doping Rule was approved. Doping Control now is conducted at all major competitions. The IAAF works together with the IOC and the other Olympic Federations with whom a joint declaration against doping was signed in 1989. In the same year, random and target testing out-of competition was initiated, and this has become a regular feature of the IAAF programme, both at national and international level.

Since 1995, the IAAF has been at the forefront of the campaign for global harmonization of all anti-doping related activities, a campaign that, ultimately in 2003, resulted in the creation of the World Anti-Doping Code. At its Congress in Paris later the same year, the IAAF accepted the World Anti-Doping Code as a basis for the fight against doping in sport and the new IAAF anti-doping rules were introduced with effect from 1March 2004. The IAAF is playing an active role in the Code revision process initiated in November 2011 and ending November 2013.

The IAAF was a forerunner in the establishment of a list of accredited laboratories around theworld and a list of prohibited substances in the seventies. The concept of accredited laboratories was then further developed by the IOC and this list, as well as the prohibited substance list, is now published by the World Anti-Doping Agency (WADA). In addition to pursuing its own programmes, the IAAF now regularly works alongside WADA and other international anti-doping organisation partners in order to maximize the effectiveness of the fight against doping in sport. The IAAF conducts an extensive anti-doping programme, including approximately 3500 annual in and out-of competition tests, scientific research and informational and educational projects and is determined to remain the leading international sports federation in this regard.

In recent years the IAAF has increasingly shown its commitment to a rigorous implementation of the Athlete Biological Passport within Athletics. This concept focusses on proving the use and effect of prohibited substances and methods by monitoring abnormal variations in an athlete’s biomarkers over time.

Preventing doping through education has been a priority for the IAAF, especially targeting young athletes. Since 2005, outreach programmes are systematically set up at major competitions with an emphasis on youth and junior events. The IAAF is committed to developing innovative and modern education tools with WADA’s support.

The IAAF, through its Medical and Anti-Doping Commission, has also been a primary contributor to the development of sports medicine through numerous publications and projects. Since 2007, the IAAF has conducted an injury surveillance programme at major competitions aiming at developing adapted prevention tools for athletes and their entourage. In 2007 The IAAF organised an international consensus conference on nutrition for athletics. In 2011, the IAAF was the first International Federation to introduce eligibility rules for females with hyperandrogenism.

Official Documents

Please find IAAF Official Documents with regards to medical and anti-doping issues by clicking the relevant links below:

Anti-Doping Official Documents

Medical Official Documents

NOW AVAILABLE: IAAF Competition Medical Guidelines - January 2013 First Edition

Official Links

World Anti-Doping Agency (WADA) website - click here

ADAMS (Anti-Doping & Administration System) login - click here

IOC World Conference on Prevention of Injury & Illness in Sport 2014: Monaco, 10 - 12 April 2014 - click here


Video - The Prohibited List Presentation